Upcoming Conference
Sacramento, April 27, 2017
Register

CLSA applauds bill to increase Medicare patient access to medical technologies

| Apr 21, 2016 | California

H.R. 5009 bridges Medicare patient access gaps and modernizes policies to allow coverage of technologies approved through FDA’s expedited review process Washington, DC (April 21, 2016) – California Life Sciences Association (CLSA), the statewide public policy organization representing over 750 of California’s leading life science innovators, lauded the introduction of...[ Read More ]

California Life Sciences Association issues statement on SB 1010

| Apr 14, 2016 | California

Sacramento, CA--California Life Sciences Association (CLSA), the statewide public policy organization representing over 750 of California’s leading life sciences innovators, issued the following statement opposing SB 1010. This statement can be attributed to Sara Radcliffe, President & CEO, California Life Sciences Association (CLSA): “As innovators in the life sciences sector...[ Read More ]

California Life Sciences Association reports on FDA drug review performance

| Mar 30, 2016 | California

California Life Sciences Association (CLSA), the leading voice to drive innovation for California’s statewide life sciences sector, today released a new infographic report on the U.S. Food and Drug Administration’s (FDA) drug review and approval times over the last 15 years. Produced in partnership with The Boston Consulting Group, the...[ Read More ]